Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,213,211 papers from all fields of science
Search
Sign In
Create Free Account
TMC 278
Known as:
278, TMC
, TMC-278
, TMC278
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
R278474
Broader (1)
Rilpivirine
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
MDR1 and BCRP Transporter-Mediated Drug-Drug Interaction between Rilpivirine and Abacavir and Effect on Intestinal Absorption
Josef Reznicek
,
M. Ceckova
,
+4 authors
F. Staud
Antimicrobial Agents and Chemotherapy
2017
Corpus ID: 3534901
ABSTRACT Rilpivirine (TMC278) is a highly potent nonnucleoside reverse transcriptase inhibitor (NNRTI) representing an effective…
Expand
2015
2015
Functionalized chitosan derivatives as nonviral vectors: physicochemical properties of acylated N,N,N-trimethyl chitosan/oligonucleotide nanopolyplexes.
Joyce C. C. Santos
,
Pedro M. D. Moreno
,
A. Mansur
,
Victoria Leiro
,
H. Mansur
,
A. P. Pêgo
Soft Matter
2015
Corpus ID: 25891448
Cationic polymers have recently attracted attention due to their proven potential for nonviral gene delivery. In this study, we…
Expand
2012
2012
Prevalence of TMC278 (rilpivirine) associated mutations in the Frankfurt Resistance Database.
C. Reinheimer
,
H. Doerr
,
M. Stürmer
Journal of Clinical Virology
2012
Corpus ID: 205933822
2012
2012
Effects of degree of quaternization on the preparation and characterization of insulin-loaded trimethyl chitosan polyelectrolyte complexes optimized by central composite design
Yun Jin
,
Dan Zhou
,
+4 authors
Yuan Huang
Pharmaceutical development and technology (Print)
2012
Corpus ID: 23780522
The aim of the present study was to investigate the effects of varying degrees of quaternization (DQ: 22, 35 and 41%) on the…
Expand
2011
2011
Monographs: Rilpivirine: a new addition to the anti-HIV-1 armamentarium.
David C. Miller
2011
Corpus ID: 8211942
2011
2011
Pooled Week 96 efficacy, resistance and safety results from the double-blind, randomised, Phase III trials comparing rilpivirine (RPV, TMC278) versus efavirenz (EFV) in treatment-naïve, HIV-1…
C. Cohen
,
C. Cohen
,
+12 authors
Helios Salud
2011
Corpus ID: 78293777
Lost to follow-up, non-compliance, withdrew consent, ineligible to continue, sponsor's decision • Similar response rates for RPV…
Expand
2011
2011
Clinical Trial Report: TMC278 (Rilpivirine) Versus Efavirenz as Initial Therapy in Treatment-Naïve, HIV-1–Infected Patients
R. MacArthur
Current Infectious Disease Reports
2011
Corpus ID: 38465749
2010
2010
Efficacy and safety of TMC278 in treatment-naïve, HIV-1-infected patients with HBV/HCV co-infection enrolled in the phase III ECHO and THRIVE trials
M. Nelson
,
G. Amaya
,
+9 authors
K. Boven
Journal of the International AIDS Society
2010
Corpus ID: 26678754
7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK
Review
2009
Review
2009
HIV/AIDS: the management of treatment-experienced HIV-infected patients: new drugs and drug combinations.
L. Wilson
,
J. Gallant
Clinical Infectious Diseases
2009
Corpus ID: 36502680
The recent availability of new antiretroviral agents for the treatment of human immunodeficiency virus (HIV) infection has…
Expand
1996
1996
Pharmacokinetic Analysis and Antiepileptic Activity of Tetra-Methylcyclopropane Analogues of Valpromide
M. Bialer
,
S. Hadad
,
+5 authors
B. Yagen
Pharmaceutical Research
1996
Corpus ID: 3162468
AbstractPurpose. The described structure pharmacokinetic pharmacodynamic relationships (SPPR) study explored the utilization of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE